Date Filed | Type | Description |
06/15/2023 |
4
| ZDRAVESKI ZORAN (Chief Legal Officer) has filed a Form 4 on TScan Therapeutics, Inc.
Txns:
| Granted 430,000 options to buy
@ $2.49, valued at
$1.1M
|
|
02/06/2023 |
4
| ZDRAVESKI ZORAN (Chief Legal Officer) has filed a Form 4 on TScan Therapeutics, Inc.
Txns:
| Granted 35,000 options to buy
@ $1.81, valued at
$63.4k
|
|
07/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/20/2022 |
4
| ZDRAVESKI ZORAN (Chief Legal Officer) has filed a Form 4 on TScan Therapeutics, Inc.
Txns:
| Granted 85,000 options to buy
@ $4.85, valued at
$412.3k
|
|
09/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/09/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/30/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/27/2018 |
4
| ZDRAVESKI ZORAN (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Converted 4,643 shares
@ $0 Converted 12,000 preferred shares
@ $0 |
|
06/20/2018 |
3
| ZDRAVESKI ZORAN (See Remarks) has filed a Form 3 on Magenta Therapeutics, Inc. |